Skip to main content
. 2019 Sep 16;9:13397. doi: 10.1038/s41598-019-49635-7

Figure 1.

Figure 1

Platelet activators rapidly trigger monocyte TF exposure in whole blood. (a,b) PPACK-anticoagulated human whole blood was stimulated with PAR1-AP (1–100 µM; 5–25 mins) prior to staining with conjugated primary antibodies. Median fluorescence intensity (MFI) is shown for TF on CD14 + monocytes (a) and P-selectin on CD41a + platelets (b) (mean + S.E.M.; n = 5; n.s. not significant p > 0.05; *p < 0.05; **p < 0.01 compared to unstimulated at the same timepoint; Friedman’s non-parametric test with Dunn’s multiple comparison post-test). (c) Whole blood was stimulated with a range of concentrations of the platelet activators, CRP-XL, PAR4-AP, and ADP, for 10 minutes. Monocyte TF and platelet P-selectin are shown on the same axes for comparison of concentration-dependency of their effects.